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Asthma is a chronic airway inflammatory disease associated with airway 
hyperresponsiveness which affects subjects with genetic predisposition. It has been 
reported an association between some polymorphisms in various cytokine genes and 
asthma. Most of them are single nucleotide polymorphisms (SNPs). These 
polymorphisms are detected in the protein coding sequence or in the promoter region 
thus influencing cytokine production. We investigated the involvement of SNPs 
mapping in 5 cytokine genes in mild to severe asthmatics from Italian Caucasians. The 
frequency of alleles and genotypes, relatively to 10 allelic specificities of the cytokine 
genes, was defined in 57 asthmatics and in 124 control subjects by a Polymerase Chain 
Reaction-Sequence Specific Primer method. 
TNF-α–308A and TNF-α –238A allele frequencies were higher in asthmatics than in 
controls (p<0.001). Significant differences in the frequency of IL-4 –590T allele and of 
IL-4Rα +1902A allele were also detected in asthmatics in comparison with controls 
(p<0.001 and p=0.005, respectively). Similarly, IL1α -889C allele was present in 84.1% 
of asthmatics and in 70.2% of controls (p=0.013). Furthermore, the IL-4Rα +1902A/A 
and IL-1α -889C/C homozygous conditions and the TNF-α -308G/A, TNF-α -238G/A, 
IL-4 -590T/C and IL-10 -1082G/A heterozygous conditions were significantly 
associated with asthma (p<0.05). ACA haplotype of IL-10 was observed only in 
asthmatic patients. This study reports, for the first time, the frequency of 10 different 
single nucleotide polymorphisms in 5 cytokine genes in the Italian Caucasians. 
Furthermore, we also indicate that in our population some single nucleotide 







According to recent literature, there is a clear association between polymorphisms in 
cytokine genes and different diseases such as transplant rejections, autoimmune 
diseases, vascular diseases and asthma (1, 2). Asthma is a chronic inflammatory disease 
of the bronchial wall (3) associated with airway hyperresponsiveness and its 
development seems to be dependent on the interaction between genetic predisposition 
and exposure to specific environmental stimuli, such as allergens, viruses and pollutants 
(4). The role of cytokines in modulating and directing the immune reaction and the 
inflammatory response of the airways is crucial in the development, progression and 
exacerbations of bronchial asthma (5). 
Tumour necrosis factor-alpha (TNF-α) is an important mediator in many cytokine-
dependent inflammatory events. Data from literature indicate that TNF-α plays a role in 
the initiation of allergic asthmatic airway inflammation and in the generation of airway 
hyperresponsiveness. Polymorphisms in the 5’ untranslated region of the TNF-α gene, 
in particular the polymorphism -308bp, have been associated with an increased risk of 
asthma and bronchial hyperresponsiveness (BHR) (6, 7). Currently, the significance of 
TNF-α -308 G/A polymorphism association to asthma in Caucasians is controversial (6, 
7) probably due to limitations of the meta-analysis related to inclusion criteria of 
published data recruited in both studies; further studies with large group of population 
are requested in order to assess the effect of these polymorphisms on asthma 
susceptibility taking into consideration the potential effect of different genetic 
backgrounds and of different environmental factors in different ethnicities. 
Furthermore, increased serum levels of TNF-α have been shown in severe asthma in 






IL-4 polymorphisms have been associated with asthma and other allergy-related 
phenotypes, although ethnical differences have been observed. For example, it has been 
reported a correlation between genetic variants in the promoter region and asthma, 
although some of these correlations are still controversial (9). 
IL-4 acts through the IL-4 receptor which consists of two subunits, the α chain (IL-4Rα) 
and the γ chain. Some SNPs localized in the coding region of the IL-4Rα gene, such as 
Q576R, have been associated with asthma and atopic phenotype (10). In addition, a 
recent study showed an association between the IL-4 promoter polymorphisms at 
positions -1098, -590, and -33 and IL-4Rα at position 1092 and asthma, and between 
the haplotypes of these polymorphisms and total IgE in asthmatic patients (11). 
In asthma the allelic variants of some cytokines, such as TNF-α and IL-4, seem to be 
clinically relevant. The aim of the present study was to evaluate the role of 
polymorphisms in genes coding asthma-related cytokines in mild to severe asthmatics 













Materials and Methods 
Subject characteristics 
A total of 57 unrelated Italian Caucasians with asthma were studied (Table I). The 
asthmatic subjects were stratified according to the GINA criteria (12). All asthmatics 
were non smokers and nobody was affected by chronic obstructive pulmonary disease 
(COPD). Positivity to the skin prick test (wheal diameter ≥3 mm greater than saline 
control) to a panel of 14 standard aeroallergens (ALK Abelló; Hørsholm, Denmark) was 
used to define allergic status in all recruited subjects. As control group, we used 124 
healthy Italian subjects (bone marrow donors).  
Forced expiratory volume in 1 second (FEV1) was measured by spirometry (Med 
Graphics, Pulmonary Function System 1070 series 2, Med Graphics Corp., St. Paul, 
MN). Normal lung function was defined if spirometric parameters ranged in the normal 
reference intervals (13). Fractional nitric oxide (NO) concentration in exhaled breath 
(FeNO) was measured by a chemiluminescence analyser (Ecomedics CLD88, Eco 
Physics AG, Duernten, Switzerland) according to the ATS/ERS recommendations (14).  
The study, conformed to the Declaration of Helsinki, was approved by the local Ethics 
Committee  (A.O.U. San Luigi Hospital: n. of protocol 35/2009), and written informed 
consent was obtained from each subject. 
 
DNA Extraction 
DNA was purified from 200 μl of peripheral blood samples with EDTA as 
anticoagulant, using the Capture Column kit (Gentra Systems, Ste 110 Plymouth, UK), 
a special purification matrix, according to the manufacturer’s procedure. Concentration 






Biophotometer, Eppendorf AG, Hamburg, Germany). DNA concentration was adjusted 
to 50-100 ng/μl while purity (ratio A260/A280) was 1.6-1.8. 
 
Gene polymorphism analysis 
Polymerase chain reaction with sequence specific primers (PCR-SSP) assay (Heidelberg 
kit, from the Institute of Immunology, University of Heidelberg, Heidelberg, Germany) 
(15) was used to assess the following cytokine polymorphisms: IL-1α –889T→C, TNF-
α –308G→A and –238G→A, IL-4 –1098T→G, –590T→C and –33T→C, IL-10 –
1082G→A, –819C→T and –592C→A and IL-4Rα +1902G→A. The PCR 
amplification was carried out using a thermocycler GeneAmp PCR System 9700 
(Perkin Elmer Inc. Waltham, MA 02451 USA) under the following conditions: initial 
denaturation at 94°C for 2 minutes followed by 10 cycles of denaturation at 94°C for 10 
seconds, annealing and extension at 65°C for 1 minute. The next 20 cycles included 10 
seconds of denaturation at 94°C, 50 seconds of annealing at 61°C and 30 seconds of 
extension at 72°C. Briefly, PCR-SSP typing by the Heidelberg kit consisted of PCR 
primer mixes aliquoted in well PCR trays. Master mix, which was supplied along with 
the reagents and consisted of MgCl2, buffer, dNTPs and glycerol, was mixed with 50-
100 ng/µl DNA and 16.5 U Taq polymerase (Applied Biosystems, Foster City, CA, 
USA). The internal control primer pairs generate a 440 bp amplification fragment (a 
part of C reactive protein gene) for IL-1α, TNF-α, IL-4Rα genes, and a 90 bp fragment 
(a part of the β-globin gene) for IL-4, IL-10 genes. The PCR products were visualized 
by 2% agarose gel electrophoresis with 0,625 mg/ml ethidium bromide.  
The identification of haplotypes GCC, ACC, ATA, ACA and ATC of the IL-10 gene 






(PROTRANS, Medizinische Diagnostische Produkte Gmbh, Hockenheim, Germany) 
according to the manufacturer’s procedure.  
 
Statistical Analysis  
The distribution of each variable was checked using the Shapiro–Wilk W test.  
Age and FeNO and FEV1 (% Pred) values were reported as median with inter-quartile 
ranges and as mean with standard deviation (SD) respectively.  
The allele and genotype frequencies were calculated by direct gene counting. The total 
was divided by the number of chromosomes in order to obtain allele and by the number 
of subjects to obtain genotype frequencies.  
For comparisons between two groups, a Mann-Whitney U test was used for non-
normally distributed quantitative data (i.e. age and FeNO), whereas a Student t test was 
used for normally distributed quantitative data [i.e. FEV1 (% Pred)]. For comparisons 
among more than two groups, a Kruskall-Wallis test followed by Bonferroni’s 
correction or ANOVA followed by Sheffè test were used when appropriate.  
A bivariate analysis was performed and the comparison of frequency between 
asthmatics and controls was made calculating the chi-square test or the Fisher’s exact 
test in case of expected frequencies less than five and reporting the bivariate odds ratio 
(OR) and 95% confidence interval (CI). Calculations were made with the chi-square-test 







The characteristics of the asthmatic and control subjects are reported in Table I.  
In the three groups of asthmatics the atopic subjects were 18 out of 26, 11 out of 14 and 
8 out of 17 for mild, moderate and severe respectively.  
The male-to-female ratio was similar in the three groups of asthmatics. FEV1 (% Pred) 
(p=0.027) and FeNO (p=0.017) were significantly different among the three groups of 
mild, moderate and severe asthmatics. As expected FEV1 (% Pred) became 
progressively lower in mild, moderate and severe asthmatics (p<0.05 for each 
comparison). In addition, lower FeNO levels were found in severe asthmatics as 
compared to mild asthmatics (p<0.05). A significant longer disease duration was found 
in severe asthmatics compared to mild asthmatics (p<0.01). 
Comparisons between atopic and non atopic patients did not reveal any significant 
difference in the analyzed parameters. 
The allele and genotype frequencies for all patients and control subjects are indicated in 
Table II and III respectively. As shown in Table II, statistical analysis, based on the 
detected frequencies, showed that the alleles TNF-α –308A, TNF-α –238A, IL-4 –590T, 
IL-4Rα +1902A and IL-1α -889C are significantly associated with mild to severe 
bronchial asthma in comparison with the control group. Differently, allele IL-10 -819T 
seems to be associated with a lower frequency in asthmatics. 
The IL-4Rα +1902A/A and IL-1α -889C/C homozygotes and the TNF-α -308G/A, 
TNF-α -238G/A, IL-4 -590T/C and IL-10 -1082G/A heterozygotes genotypes were 
significantly more frequent in asthmatics compared to the control group (Table III). On 
the contrary, the IL-4Rα +1902G/A and IL-1α –889T/C heterozygotes genotypes were 






Finally, GCC, ACC, ATA and ATC haplotypes of IL-10 gene do not seem to be 
associated with asthma in our population (Table IV). On the other hand, ACA haplotype 
of IL-10 was observed only in asthmatic patients (4.9%) (Table IV). 
We did not find any significant correlation between FEV1 or FeNO and the alleles, 
genotypes or IL-10 haplotypes that showed a significant difference between asthmatics 

























This is the first study that investigates the role of polymorphisms in multiple cytokine 
genes in asthma among Italian Caucasians. 
Our results suggest that TNF-α –308A, TNF-α –238A, IL-4 -590T, IL-4Rα +1902A and 
IL-1α –889C alleles are associated with mild to severe asthma in adults. Furthermore, 
the IL-4Rα +1902A/A and IL-1α -889C/C homozygotes and the TNF-α -308G/A, TNF-
α -238G/A, IL-4 –590T/C and IL-10 -1082G/A heterozygotes genotypes are 
significantly more frequent in asthmatics compared to the control group.  
TNF-α 
Our data indicate that the frequency of TNF-α -308A allele, which is the less frequent 
allele in the general population, is higher in asthmatics than in normal individuals. 
These findings are in agreement with several independent studies (6, 7, 16), but on the 
light of other negative studies (6, 7, 17) the effects of this genetic variant in asthma are 
still controversial. Discrepancies among these studies could be due to the small sample 
sizes or to a gene able to affect asthma phenotypes in linkage disequilibrium with TNF-
α (18). Nevertheless, our data are supported by the observation that the TNF-α -308A 
allele is associated with elevated TNF-α transcriptional activity and this is not surprising 
because the -308 polymorphism is localized in the promoter region (19). Increased 
levels of TNF-α have been demonstrated to cause an increase in airway hyper-reactivity 
by increased airway smooth muscle responsiveness and/or producing a cascade of 
inflammatory responses with the release of mediators (20). 
We recently showed an increase in serum levels of TNF-α in severe asthma patients 






children with the TNF-α -308A allele under home dampness exposure had an increased 
risk on asthma-related health outcomes (21).  
In our samples set the frequency of the TNF-α -238A polymorphism was higher in 
asthmatic group compared to control group. This allele has been associated with an 
increased childhood asthma risk in children with non-smoking parents (22). This 
polymorphism maps in the promoter, but unlike the TNF-α -308 one, it does not seem to 
have a direct effect on gene expression, although this region (-280 to -172) contains a 
strong repressor site (23). However, the TNF-α -238A genetic variant may be in linkage 
disequilibrium with a functional polymorphism, either within the TNF-α gene or 
another gene within the MHC, that influences the TNF production. 
IL-4 
Our results indicate that frequency of the T base at position -590 of the IL-4 gene 
promoter region is higher among asthmatic patients compared to control subjects. The 
IL4 -590T allele, which is present in approximately 27% of Caucasians, has been 
associated with increased gene transcription and with higher levels of in vivo IgE (11). 
The IL4 -590T polymorphism has been related to asthma in different populations, to 
atopy and decreased pulmonary function (9, 11). It has been associated with low values 
of forced expiratory volume in 1 second (FEV1) in a Caucasian population with asthma 
(24) and has been reported that the IL4 -590T allele influences asthma severity (9). 
However, the role of this polymorphism in asthma is still controversial because some 
authors did not find any correlation between this variant and asthma (25). On the basis 
of this observation we can speculate that the differences of the literature data regarding 






asthma severity among the analyzed patients. Noteworthy, 31 of the 57 patients 
collected in our study were moderate-severe asthmatics. 
IL-4Rα 
As reported by multiple studies in different populations (9-11), we found that the IL-
4Rα +1902A polymorphism is associated with asthma in Italian population. On the 
other hand, other studies failed to detect a correlation between this genetic variant and 
asthma (26). The IL-4Rα +1902A polymorphism produces the aminoacid substitution 
from glutamine to arginine at codon 576 (Q576R) in the cytoplasmatic domain of the 
receptor. The combination of this genetic variant with the IL-4Rα I75V polymorphism 
has been reported to enhance CD23 induction in response to IL-4 in B-lymphocytes 
isolated from allergic patients and to be associated with allergic asthma (27). We 
speculate that the discrepancy between studies that found or did not an association of 
this polymorphism with asthma is due to a selection of subjects bearing or not the I75V 
polymorphism in addition to the Q576R genetic variant. A study in Chinese children 
strengthen this hypothesis demonstrating by haplotype analysis that the G-A and A-A 
haplotypes consisting of IL-4Rα I75V and IL-4Rα Q576R are significantly associated 
with asthma; in addition the authors showed significant gene-gene interactions among 
six genes including IL-4Rα I75V and IL-4Rα Q576R that may increase an individual’s 
susceptibility to asthma and contribute to the pathogenesis of asthma (28). 
IL-1α 
We observed that the frequency of IL1α -889C polymorphism was higher in asthmatic 
patients as compared to controls. In addition, we detected that the carriers of CC 






Unfortunately, the correlation between this genotype and asthma disease is poorly 
documented in literature. 
IL-10 
In our study the IL-10 polymorphisms at positions -819C→T and -592C→A and the 
GCC, ACC, ATA, and ATC haplotypes were not related to asthma; on the contrary, the 
IL-10 -1082G→A polymorphism showed a significant association to asthma. Negative 
results are in accordance with a previous report (29). Indeed other studies reported weak 
relations between IL-10 polymorphisms and asthma: the IL-10 -592CA genetic 
variant has been weakly associated with asthma disease (30); the IL-10 -592 A/C and 
the -819 T/C polymorphisms, the ATA and the ACC haplotypes were shown to be 
related to serum eosinophil cationic protein (ECP) in asthmatic Korean children (31). 
The GCC haplotype has been found to be related to high IgE levels and FEV1 in 
asthmatic patients (32). About IL-10 –1082 G/A polymorphism, a positive association 
of this SNP and ATA haplotype with asthma has been reported in North Indian 
population (33) and with airway hyperresponsiveness in Korean children (31). The IL-
10 –1082 G/A polymorphism was also associated with both atopic and non-atopic 
asthma in Egyptian children and heterozigosity or homozigosity for the risk allele of the 
-1082 A/G was significantly associated with increased total IgE but not IL-10 serum 
levels (34). Furthermore, in our studied population, ACA haplotype was observed only 
in asthmatic patients. The discrepancies of results reported in literature could be 
explained by the small size of samples set analyzed, different allelic distribution among 
different populations, linkage disequilibrium or by differences of specificity and 






Finally, the IL-10 -819T allele and the IL-4Rα +1902GA and IL-1α –889TC 
heterozygotes genotypes resulted more frequent in the control group as compared to 
asthmatics; unfortunately, the correlation between these conditions and a protective role 
against asthma disease is, to our knowledge, poorly documented in literature. 
 
The present study is in line with a recent paper that showed in Iranian population an 
higher frequency of TNF- and other cytokines polymorphisms in asthmatics compared 
to controls (35). In our study we did not find associations between cytokine 
polymorphisms and severity, pulmonary function or FeNO levels but in the latter paper 
the authors showed that low producer of TNF- (-308GG) genotype, and TNF- (-
308G) and IL-6 (-174C) alleles were associated with reduced FEF25–75 but no 
significant association was observed between cytokine polymorphisms and the amount 
of asthma control. These data suggest that asthma is a multifactorial disease dependent 
on genetic predisposition, environmental, inflammatory and non-inflammatory factors 
that interacts in a complex biological response in relation to clinical expression which 
characterizes the different clinical-biological phenotyping in asthma (36). 
In summary, although previous studies have investigated the role of polymorphisms in 
few cytokine genes among Italian asthmatic patients, this is the first study that describes 
the allele and genotype frequencies of polymorphisms in several cytokine genes in mild 
to severe Italian asthmatics, suggesting that the TNF-α –308A, TNF-α –238A, IL-4 –
590T, IL-4Rα +1902A and IL-1α -889C polymorphisms are positively associated with 
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p=0.027 among the three asthmatic groups; 
†
p=0.017 among the three asthmatic groups; 
‡















Cytokine % Controls % Asthmatics OR 95%CI p 
– 308A TNF-α 8.1 27.7 4.36 2.35-8.08 <0.0001 
– 238A TNF-α 5.3 17.0 3.69 1.75-7.78 0.0002 
– 33T IL-4 10.1 13.9 1.45 0.69-3.02 0.324 
– 590T IL-4 7.3 20.7 3.33 1.66-6.67 0.0004 
– 1098G IL-4 12.1 8.5 0.68 0.29-1.61 0.376 
– 1098T IL-4 87.9 87.8 1.47 0.62-3.50 0.376 
+ 1902A IL-4Rα 79 92.7 3.36 1.39-8.15 0.005 
– 889C IL-1α 70.2 84 2.26 1.18-4.33 0.013 
– 1082A IL-10 61 58.5 0.91 0.55-1.51 0.71 
– 819T IL-10 32 17 0.44 0.23-0.83 0.0099 
– 592A IL-10 27 22 0.76 0.42-1.38 0.36 
P values refer to chi-square test, unless otherwise specificied; 
# 
Fisher’s Exact test; OR: 














Cytokine % Controls % Asthmatics OR 95%CI p 
– 308AA TNF-α 3.3 8.9 2.94 0.78-11.40 0.139# 
– 308GA TNF-α 9.7 37.5 5.60 2.51-12.52 <0.0001 
– 238AA TNF-α 1.7 0 0 - 1.000# 
– 238GA TNF-α 7.3 33.9 6.56 2.73-15.75 <0.0001 
– 33TT IL-4 2.5  0 0 - 0.572# 
– 33CT IL-4 15.3  28.6 2.21 0.97-5.06 0.06 
– 590TT IL-4 2.4 4.3 1.83 0.30-11.34 0.613# 
– 590TC IL-4 9.6 32.6 4.52 1.92-10.84 0.0003 
– 1098GG IL-4 0 0 - - - 
–1098GT IL-4 24.2 17.1 0.65 0.26-1.60 0.343 
– 1098TT IL-4 75.8 82.9 1.55 0.62-3.86 0.343 
+ 1902AA IL-4Rα 64.5 87.8 3.96 1.45-10.82 0.005 
+ 1902GA IL-4Rα 29 9.8 0.30 0.10-0.88 0.020 






– 889TC IL-1α  33.8  12.3 0.32 0.12-0.83 0.015 
– 1082AA IL-10 31.5 19.5 0.53 0.22-1.25 0.14 
– 1082GA IL-10 58.8 78 2.48 1.09-5.65 0.027 
– 819TT IL-10 12 2.4 0.18 0.02-1.42 0.12# 
– 819CT IL-10 39.5 29.3 0.70 0.35-1.38 0.300 
– 592AA IL-10 9 7.3 0.81 0.21-3.06 1.00# 
– 592CA IL-10 36.3 29.3 0.77 0.39-1.55 0.466 
P values refer to chi-square test, unless otherwise specificied; 
# 
Fisher’s Exact test; OR: 




























% Normal % Asthmatics OR 95%CI p 
GCC 39.1 41.5 1.10 0.66-1.83 0.71 
ACC 29.1 35.4 1.34 0.79-2.27 0.28 
ATA 27 17 0.56 0.29-1.05 0.07 
ACA 0 4.9 nc nc 0.004# 
ATC 4.8 1.2 0.24 0.03-1.90 0.20# 
P values in the table refer to chi-square test, unless otherwise specificied; # Fisher’s 
Exact test; OR: odds ratios; 95% CI: 95% Confidence Interval; nc: not calculable. 
 
 
 
 
 
 
